Read More
Photos showing Pluristem CEO and COO Yaky Yanai, and Pluristem trials

Israeli and Emirati companies join forces to develop COVID-19 treatment

The Israeli-Emirati joint projects aim to utilize each company's strengths in order to achieve results that will integrate the expertise of both companies.

FDA clears Haifa-based Pluristem’s COVID-19 Expanded Access Program

More coronavirus patients who do not qualify for the company’s clinical trial will now be able to receive treatment

Israel’s Pluristem: 75% of treated COVID-19 patients off ventilators

The survival rate is 87.5%, Pluristem Therapeutics reported.

bioreactor pluristem

Israel's Pluristem FDA approved for study in treatment of severe COVID-19

Six critically ill coronavirus patients in Israel who were considered high-risk for mortality were treated with Pluristem and survived.

Israel's Pluristem secures €50m. EU financing to boost COVID-19 treatment

The financing is backed by a guarantee from the European Fund for Strategic Investments (EFSI), the financial pillar of the European Union's Investment Plan for Europe.

A Pluristem scientist in the process of making its cell products and a look at the final product its

Israeli COVID-19 treatment with 100% survival rate tested on US patient

After one week, six critically ill patients in Israel survived. Four of them showed improvement in respiratory parameters.

Biologists work in a laboratory at Pluristem Therapeutics Inc. in Haifa

Israeli COVID-19 treatment shows 100% survival rate - preliminary data

Not only have all the patients survived, according to Pluristem, but four of them showed improvement in respiratory parameters.

Biologists work in a laboratory at Pluristem Therapeutics Inc. in Haifa

Pluristem’s potential new breakthrough

Haifa company weeks away from presenting clinical trial results that could ‘generate hope’ for patients suffering from untreatable vascular disease.


Smart cells that heal

Innovative Israeli cell therapy could step up treatment of CLI.

Pluristen chairman and co-CEO Zami Aberman holds a vial of specialized stem cells the company calls

New hope for cancer patients

Cancer is a leading cause of death around the world and its incidence continues to rise. Each year around 12.7 million people discover they have cancer and 7.6 million people die from it.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy